charbent3

Meeting the Cancer Challenge Together

CIHR Fall 2024

Charbonneau Investigators receive 2024 CIHR Project Grants

Congratulations to our Charbonneau Investigators who have championed and contributed to successful CIHR Fall 2024 Project Grants.

Read more


Celebrating 10 Years of the Arnie Charbonneau Cancer Institute

The Arnie Charbonneau Cancer Institute is a partnership between the University of Calgary and Alberta Health Services, bringing together scientists and clinicians to integrate research and care cross disciplines – from understanding and preventing cancer, to transforming its detection and treatment, to improving life with and after cancer.

Since 2014, the Charbonneau has become a dynamic hub where researchers and clinicians converge to push boundaries. Over the past ten years, we have worked to foster this new era of innovation, collaboration, and meeting the cancer challenge.

Learn more about the past, present, and future of cancer research at the Charbonneau


Learn About Us

Learn About Us

Research

Research

Train with us

Train with Us

Need to get in touch? Connect with us

In the News

UCalgary researchers among network receiving $5 million for new cancer research program

Canadian Cancer Society grant to study benefits of psychedelics for late-stage cancer

Philanthropy powers UCalgary research team using real-world evidence to improve cancer treatments

Calgary family’s $2M gift helps Oncology Outcomes (O2) team make data research discoveries benefiting breast, kidney and lung cancer patients

UCalgary researchers help preserve future fertility options for children impacted by cancer

Next to survival, fertility is the No. 1 concern for young patients and their parents

Six UCalgary researchers receive renewals of Canada Research Chairs

Combined with eight new CRC appointments, UCalgary receives more than $10 million in funding

UCalgary research reveals how special cells act as ‘sentinels’ of the immune system

Groundbreaking finding by Faculty of Veterinary Medicine team opens door to new immunotherapies and enhanced vaccines